Chemoinformaics analysis of 2-O-(BETA-L-ARABINOPYRANOSYL)-MYOINOSITOL
Molecular Weight | 312.271 | nRot | 2 |
Heavy Atom Molecular Weight | 292.111 | nRig | 12 |
Exact Molecular Weight | 312.106 | nRing | 2 |
Solubility: LogS | 0.022 | nHRing | 1 |
Solubility: LogP | -3.281 | No. of Aliphatic Rings | 2 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
Atoms Count | 41 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 21 | No. of Aromatic Carbocycles | 0 |
nHetero | 10 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 1 |
No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 1 |
No. of Carbon atom | 11 | No. of Saturated Rings | 2 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 10 | No. of Arom Bond | 0 |
nHA | 10 | APOL | 39.7259 |
nHD | 8 | BPOL | 23.5361 |
QED | 0.245 |
Synth | 4.154 |
Natural Product Likeliness | 1.781 |
NR-PPAR-gamma | 0.005 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0.002 |
Pgp-sub | 0.846 |
HIA | 0.991 |
CACO-2 | -5.72 |
MDCK | 0.000380785 |
BBB | 0.605 |
PPB | 0.141152 |
VDSS | 0.319 |
FU | 0.614363 |
CYP1A2-inh | 0.002 |
CYP1A2-sub | 0.011 |
CYP2c19-inh | 0.003 |
CYP2c19-sub | 0.043 |
CYP2c9-inh | 0 |
CYP2c9-sub | 0.083 |
CYP2d6-inh | 0 |
CYP2d6-sub | 0.084 |
CYP3a4-inh | 0.002 |
CYP3a4-sub | 0.001 |
CL | 1.211 |
T12 | 0.516 |
hERG | 0.087 |
Ames | 0.097 |
ROA | 0.048 |
SkinSen | 0.014 |
Carcinogencity | 0.008 |
EI | 0.008 |
Respiratory | 0.026 |
NR-Aromatase | 0.004 |
Antiviral | Yes |
Prediction | 0.771367 |